4SC AG Valor da empresa
Qual é o Valor da empresa de 4SC AG?
O Valor da empresa de 4SC AG é -$12.03
Qual é a definição de Valor da empresa?
O valor da empresa é uma medida do valor total de mercado de uma empresa. É calculado como capitalização de mercado com dívida, participação minoritária e ações preferenciais menos o total de caixa e equivalentes de caixa.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valor da empresa de empresas na Setor Health Care em XETRA em comparação com 4SC AG
O que 4SC AG faz?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Empresas com valor da empresa semelhantes a 4SC AG
- Hydraulique P.B Societe anonyme tem Valor da empresa de -$12.42
- Brand Architekts plc tem Valor da empresa de -$12.30
- Ocean Line Port Development tem Valor da empresa de -$12.28
- Neptune Wellness Solutions tem Valor da empresa de -$12.24
- Wisdom Sports tem Valor da empresa de -$12.18
- Orphazyme A/S tem Valor da empresa de -$12.12
- 4SC AG tem Valor da empresa de -$12.03
- Trilogy International Partners tem Valor da empresa de -$12.02
- Watchstone Plc tem Valor da empresa de -$11.75
- 360 Ludashi tem Valor da empresa de -$11.41
- KOALA tem Valor da empresa de -$11.26
- Sing Tao News tem Valor da empresa de -$11.07
- Amuse tem Valor da empresa de -$10.86